Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol
Tabelecleucel 用于治疗异基因造血干细胞移植或实体器官移植后 EBV 阳性 PTLD 的多中心扩大用药方案
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2023011626
Nikiforow, Sarah; Whangbo, Jennifer S; Reshef, Ran; Tsai, Donald E; Bunin, Nancy; Abu-Arja, Rolla; Mahadeo, Kris Michael; Weng, Wen-Kai; Van Besien, Koen; Loeb, David; Nasta, Sunita Dwivedy; Nemecek, Eneida R; Zhao, Weizhi; Sun, Yan; Galderisi, Faith; Wahlstrom, Justin; Mehta, Aditi; Gamelin, Laurence; Dinavahi, Rajani; Prockop, Susan